These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10754207)

  • 1. Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer.
    Matsumoto S; Minobe K; Utada Y; Furukawa K; Onda M; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer Lett; 2000 Apr; 152(1):63-9. PubMed ID: 10754207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
    Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer.
    Emi M; Yoshimoto M; Sato T; Matsumoto S; Utada Y; Ito I; Minobe K; Iwase T; Katagiri T; Bando K; Akiyama F; Harada Y; Fukino K; Sakamoto G; Matsushima M; Iida A; Tada T; Saito H; Miki Y; Kasumi F; Nakamura Y
    Genes Chromosomes Cancer; 1999 Oct; 26(2):134-41. PubMed ID: 10469451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
    Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor beta2 expression in breast carcinoma.
    Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Shan L; Suzuma T; Tamaki T; Umemura T; Mori I; Kakudo K
    Breast Cancer Res Treat; 2001 Nov; 70(1):39-45. PubMed ID: 11767003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of allelic losses at 3p25.1, 13q12, or 17p13.3 with poor prognosis in breast cancers with lymph node metastasis.
    Haga S; Emi M; Hirano A; Utada Y; Kajiwara T; Akiyama F; Sakamoto G; Takahashi K; Tada T; Kasumi F; Miki Y; Nakamura Y
    Jpn J Cancer Res; 2001 Nov; 92(11):1199-206. PubMed ID: 11714444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
    Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy.
    Tsuneizumi M; Emi M; Hirano A; Utada Y; Tsumagari K; Takahashi K; Kasumi F; Akiyama F; Sakamoto G; Kazui T; Nakamura Y
    Cancer Lett; 2002 Jun; 180(1):75-82. PubMed ID: 11911973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas.
    de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ
    Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity at different chromosomes in patients with breast cancer].
    Deng GR; He LW; Lin BY
    Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):31-4, 63-4. PubMed ID: 7913405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer.
    Qiu H; Lotan R; Lippman SM; Xu XC
    Genes Chromosomes Cancer; 2000 Jun; 28(2):196-202. PubMed ID: 10825004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 9 in human breast cancer: association with clinical variables and genetic changes at other chromosome regions.
    Eiriksdottir G; Sigurdsson A; Jonasson JG; Agnarsson BA; Sigurdsson H; Gudmundsson J; Bergthorsson JT; Barkardottir RB; Egilsson V; Ingvarsson S
    Int J Cancer; 1995 Dec; 64(6):378-82. PubMed ID: 8550238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of two separate regions on chromosome 3p in breast cancers.
    Chen LC; Matsumura K; Deng G; Kurisu W; Ljung BM; Lerman MI; Waldman FM; Smith HS
    Cancer Res; 1994 Jun; 54(11):3021-4. PubMed ID: 7910519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular abnormalities associated with secretory carcinomas of the breast.
    Maitra A; Tavassoli FA; Albores-Saavedra J; Behrens C; Wistuba II; Bryant D; Weinberg AG; Rogers BB; Saboorian MH; Gazdar AF
    Hum Pathol; 1999 Dec; 30(12):1435-40. PubMed ID: 10667421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.